Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110683979B details a novel NaOH-catalyzed route to polysubstituted pyrroles from aurones, offering high yields and eliminating heavy metal residues for reliable pharmaceutical intermediate supply.
Patent CN100418953C reveals a novel telmisartan synthesis route eliminating needle crystallization issues, ensuring high purity and cost reduction in pharmaceutical manufacturing.
Novel Pd-catalyzed C-O coupling method for aryl esters. High yield up to 95%. Ideal for pharmaceutical intermediates. Cost-effective and scalable process.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable production for global API manufacturers.
Novel binaphthyl phosphoric acid catalyzed route offers mild conditions and high purity for scalable pharmaceutical intermediate manufacturing supply chains and cost reduction.
Patent CN114634482B reveals efficient hypervalent iodine route for difluoromethyl building blocks, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed carbonylation method offers high efficiency and scalability for quinoline-4(1H)-one manufacturing supply chain.
Patent CN107216326B enables mild synthesis of phenanthridine derivatives, ensuring high purity and supply chain stability for pharmaceutical intermediates globally.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering superior yields and scalable manufacturing for pharmaceutical intermediates.
Patent CN113307790B reveals a metal-free synthesis for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112645909B details air-stable nickel catalysis for alpha-benzylbenzofuran. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel Lewis acid catalyzed process for aromatic sulfinic acids reduces waste and energy. Reliable supply chain solution for pharmaceutical intermediate manufacturing partners.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108659028B details a novel palladium-catalyzed trans-carboboration method for synthesizing high-purity fluorochemical intermediates with improved supply chain efficiency.
Patent CN112778261B details a mild silver-catalyzed route to isocoumarins, offering cost-effective manufacturing and scalable supply chain solutions.
Patent CN109384789B details a mild Ag(I)-catalyzed route to indoloazepines, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN119330863A reveals air-stable synthesis reducing heavy metal use. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity standards.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.